POSTANTIBIOTIC EFFECTS AND POSTANTIBIOTIC SUB-MIC EFFECTS OF ROXITHROMYCIN, CLARITHROMYCIN, AND AZITHROMYCIN ON RESPIRATORY-TRACT PATHOGENS

被引:46
作者
ODENHOLTTORNQVIST, I
LOWDIN, E
CARS, O
机构
[1] Department of Infectious Diseases, University Hospital
关键词
D O I
10.1128/AAC.39.1.221
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pharmacodynamic parameters have become increasingly important for the determination of the optimal dosing schedules of antibiotics. In this study, the postantibiotic effects (PAEs), the postantibiotic sub-MIC effects (SMEs), and the sub-MIC effects (SMEs) of roxithromycin, clarithromycin, and azithromycin on reference strains of Streptococcus pyogenes group A, Streptococcus pneumoniae, and Haemophilus influenzae were investigated. The PAE was induced by 2x MICs (S. pneumoniae) or 10x MICs of the different drugs for 2 h, and the antibiotics were eliminated by washing and dilution. The PA SMEs were studied by addition of 0.1, 0.2, and 0.3x MICs during the postantibiotic phase of the bacteria, and the SMEs were studied by exposition of the bacteria to the drugs at the sub MICs only. Growth curves were followed by viable counts for 24 h. The SMEs were generally very short. A PAE of 2.9 to 8 h was noted for all antibiotics against all strains. Clarithromycin induced a statistically significantly shorter PAE on S. pneumoniae than did roxithromycin and azithromycin and did so also against H. influenzae in comparison with azithromycin. The PA SMEs were long and varied at 0.3x MIC between 6.4 19.6 h. This pronounced suppression of regrowth of bacteria which are first treated with a suprainhibitory concentration of antibiotics and then reexposed to sub MIC levels indicates that long dosing intervals for macrolides and azalides can be allowed.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 36 条
[11]   FACTORS AFFECTING DURATION OF INVIVO POSTANTIBIOTIC EFFECT FOR AMINOGLYCOSIDES AGAINST GRAM-NEGATIVE BACILLI [J].
FANTIN, B ;
EBERT, S ;
LEGGETT, J ;
VOGELMAN, B ;
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (06) :829-836
[12]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[13]   HAEMOPHILUS-INFLUENZAE RESIDES AND MULTIPLIES INTRACELLULARLY IN HUMAN ADENOID TISSUE AS DEMONSTRATED BY IN-SITU HYBRIDIZATION AND BACTERIAL VIABILITY ASSAY [J].
FORSGREN, J ;
SAMUELSON, A ;
AHLIN, A ;
JONASSON, J ;
RYNNELDAGOO, B ;
LINDBERG, A .
INFECTION AND IMMUNITY, 1994, 62 (02) :673-679
[14]   POTENTIATION OF OPSONIZATION AND PHAGOCYTOSIS OF STREPTOCOCCUS-PYOGENES FOLLOWING GROWTH IN THE PRESENCE OF CLINDAMYCIN [J].
GEMMELL, CG ;
PETERSON, PK ;
SCHMELING, D ;
KIM, Y ;
MATHEWS, J ;
WANNAMAKER, L ;
QUIE, PG .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1249-1256
[15]   ANTIBIOTIC-THERAPY OF INFECTIONS DUE TO PSEUDOMONAS-AERUGINOSA IN NORMAL AND GRANULOCYTOPENIC MICE - COMPARISON OF MURINE AND HUMAN PHARMACOKINETICS [J].
GERBER, AU ;
BRUGGER, HP ;
FELLER, C ;
STRITZKO, T ;
STALDER, B .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :90-97
[16]   GROWTH-KINETICS OF RESPIRATORY PATHOGENS AFTER SHORT EXPOSURES TO AMPICILLIN AND ERYTHROMYCIN INVITRO [J].
GERBER, AU ;
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :81-91
[17]   AZITHROMYCIN VERSUS CEFACLOR IN THE TREATMENT OF ACUTE BACTERIAL PNEUMONIA [J].
KINASEWITZ, G ;
WOOD, RG .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :872-877
[18]   POSTANTIBIOTIC EFFECT OF ROXITHROMYCIN, ERYTHROMYCIN, AND CLINDAMYCIN AGAINST SELECTED GRAM-POSITIVE BACTERIA AND HAEMOPHILUS-INFLUENZAE [J].
KUENZI, B ;
SEGESSENMANN, C ;
GERBER, AU .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :39-46
[19]  
KUNIN CM, 1981, REV INFECT DIS, V3, P4
[20]   COMPARATIVE ANTIBIOTIC DOSE-EFFECT RELATIONS AT SEVERAL DOSING INTERVALS IN MURINE PNEUMONITIS AND THIGH-INFECTION MODELS [J].
LEGGETT, JE ;
FANTIN, B ;
EBERT, S ;
TOTSUKA, K ;
VOGELMAN, B ;
CALAME, W ;
MATTIE, H ;
CRAIG, WA .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :281-292